vs
Side-by-side financial comparison of Farmland Partners Inc. (FPI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Farmland Partners Inc. is the larger business by last-quarter revenue ($20.7M vs $18.3M, roughly 1.1× ROCKWELL MEDICAL, INC.). Farmland Partners Inc. runs the higher net margin — 103.4% vs -3.0%, a 106.4% gap on every dollar of revenue. On growth, Farmland Partners Inc. posted the faster year-over-year revenue change (-3.5% vs -25.6%). Over the past eight quarters, Farmland Partners Inc.'s revenue compounded faster (31.4% CAGR vs -10.1%).
Farmland Industries was the largest agricultural cooperative in North America when it eventually sold all of its assets in 2002–04. During its 74-year history, Farmland served its farmer membership as a diversified, integrated organization, playing a significant role in agricultural markets both domestically and worldwide.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
FPI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.7M | $18.3M |
| Net Profit | $21.4M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 103.4% | -3.0% |
| Revenue YoY | -3.5% | -25.6% |
| Net Profit YoY | -63.5% | 26.7% |
| EPS (diluted) | $0.44 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.7M | $18.3M | ||
| Q3 25 | $11.3M | $15.9M | ||
| Q2 25 | $10.0M | $16.1M | ||
| Q1 25 | $10.3M | $18.9M | ||
| Q4 24 | $21.5M | $24.7M | ||
| Q3 24 | $13.3M | $28.3M | ||
| Q2 24 | $11.4M | $25.8M | ||
| Q1 24 | $12.0M | $22.7M |
| Q4 25 | $21.4M | $-554.0K | ||
| Q3 25 | $483.0K | $-1.8M | ||
| Q2 25 | $7.6M | $-1.5M | ||
| Q1 25 | $2.0M | $-1.5M | ||
| Q4 24 | $58.7M | $-756.0K | ||
| Q3 24 | $1.8M | $1.7M | ||
| Q2 24 | $-2.0M | $343.0K | ||
| Q1 24 | $1.4M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | 4.3% | -9.9% | ||
| Q2 25 | 78.2% | -8.4% | ||
| Q1 25 | 20.6% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | 13.9% | 6.8% | ||
| Q2 24 | -17.9% | 2.0% | ||
| Q1 24 | 11.9% | -5.8% |
| Q4 25 | 103.4% | -3.0% | ||
| Q3 25 | 4.3% | -11.0% | ||
| Q2 25 | 76.3% | -9.3% | ||
| Q1 25 | 19.9% | -8.0% | ||
| Q4 24 | 273.6% | -3.1% | ||
| Q3 24 | 13.5% | 5.9% | ||
| Q2 24 | -17.5% | 1.3% | ||
| Q1 24 | 11.5% | -7.6% |
| Q4 25 | $0.44 | $-0.01 | ||
| Q3 25 | $0.00 | $-0.05 | ||
| Q2 25 | $0.14 | $-0.05 | ||
| Q1 25 | $0.03 | $-0.04 | ||
| Q4 24 | $1.09 | $-0.02 | ||
| Q3 24 | $0.02 | $0.04 | ||
| Q2 24 | $-0.06 | $0.01 | ||
| Q1 24 | $0.01 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | $161.6M | — |
| Stockholders' EquityBook value | $467.4M | $37.0M |
| Total Assets | $719.1M | $57.1M |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $161.6M | — | ||
| Q3 25 | $170.4M | — | ||
| Q2 25 | $193.4M | — | ||
| Q1 25 | $202.6M | — | ||
| Q4 24 | $204.6M | — | ||
| Q3 24 | $394.0M | — | ||
| Q2 24 | $393.0M | — | ||
| Q1 24 | $383.0M | — |
| Q4 25 | $467.4M | $37.0M | ||
| Q3 25 | $457.3M | $37.0M | ||
| Q2 25 | $473.5M | $30.4M | ||
| Q1 25 | $492.2M | $31.5M | ||
| Q4 24 | $494.6M | $32.6M | ||
| Q3 24 | $519.4M | $29.1M | ||
| Q2 24 | $521.5M | $23.5M | ||
| Q1 24 | $526.7M | $20.6M |
| Q4 25 | $719.1M | $57.1M | ||
| Q3 25 | $738.5M | $57.5M | ||
| Q2 25 | $776.7M | $52.6M | ||
| Q1 25 | $810.5M | $54.0M | ||
| Q4 24 | $869.6M | $59.2M | ||
| Q3 24 | $1.0B | $57.1M | ||
| Q2 24 | $1.0B | $53.0M | ||
| Q1 24 | $1.0B | $50.7M |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.41× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 0.73× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.4M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 0.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.4M | $2.3M | ||
| Q3 25 | $-2.0M | $-1.3M | ||
| Q2 25 | $-2.2M | $1.8M | ||
| Q1 25 | $6.4M | $-3.5M | ||
| Q4 24 | $16.1M | $865.0K | ||
| Q3 24 | $-4.3M | $4.3M | ||
| Q2 24 | $-6.1M | $1.4M | ||
| Q1 24 | $11.9M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 0.81× | — | ||
| Q3 25 | -4.04× | — | ||
| Q2 25 | -0.29× | — | ||
| Q1 25 | 3.12× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | -2.39× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 8.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FPI
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
